BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cha Z, Zang Y, Guo H, Gu H, Tu X, Song H, Qian B. RETRACTED ARTICLE: Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma. Mol Biol Rep 2014;41:1165-70. [DOI: 10.1007/s11033-013-2963-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu S, Yang S, Sun G, Huang W, Zhang Y. Transforming growth factor-beta polymorphisms and serum level in the development of osteosarcoma. DNA Cell Biol 2014;33:802-6. [PMID: 25098449 DOI: 10.1089/dna.2014.2527] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
2 Wei W, You Z, Sun S, Wang Y, Zhang X, Pang D, Jiang Y. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer. Mol Carcinog 2018;57:988-96. [PMID: 29603419 DOI: 10.1002/mc.22819] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
3 Li J, Mai J. Polymorphism in interleukin 21 gene is associated with decreased susceptibility to diffuse large B cell lymphoma. Tumour Biol 2014;35:11295-300. [PMID: 25117075 DOI: 10.1007/s13277-014-2440-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]